Skip to content

Drug interactions

Chlorpheniramine + Tucatinib

Severity: Minor

Chlorpheniramine and Tucatinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tucatinib is a moderate CYP3A inhibitor and may raise chlorpheniramine exposure, though chlorpheniramine is not a sensitive CYP3A substrate with a narrow therapeutic index. The expected result is greater sedation and anticholinergic effects.

What this interaction means in plain words

Chlorpheniramine and Tucatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Chlorpheniramine belongs to Respiratory; Tucatinib belongs to Oncology.

Evidence level: Low

Why it happens

Inhibition of CYP3A-mediated metabolism of chlorpheniramine by tucatinib.

What to do

No routine dose change is needed. Monitor for increased drowsiness or anticholinergic effects and reduce the antihistamine dose if they occur.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Chlorpheniramine and Tucatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Chlorpheniramine with Tucatinib?

MediHelp rates the interaction as minor. Chlorpheniramine and Tucatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Tucatinib is a moderate CYP3A inhibitor and may raise chlorpheniramine exposure, though chlorpheniramine is not a sensitive CYP3A substrate with a narrow therapeutic index. The expected result is greater sedation and anticholinergic effects.

How serious is the interaction between Chlorpheniramine and Tucatinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed. Monitor for increased drowsiness or anticholinergic effects and reduce the antihistamine dose if they occur.

What other medicines interact with Chlorpheniramine?

MediHelp also lists interactions of Chlorpheniramine with, for example, Belladonna and opium, Benzhydrocodone / acetaminophen, Brexanolone. The full list is on the Chlorpheniramine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in